Search
  • 網站搜尋
亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台,協助業界發掘知識產權貿易商機,並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權,或是製造商需要購買技術以提高操作效能,又或是知識產權配套服務供應商,你將會從本網站發掘到有用的知識產權貿易資訊。
返回搜索結果

Novel Diabetes Treatment


總結

Researchers at Purdue University in collaboration with Oklahoma Medical Research Foundation have developed and assayed a series of lead compounds that act as memapsin 1 inhibitors and increase pancreatic beta cell mass. Treatment with these compounds may also be complimented by other therapeutics that increase insulin production, improve glucose homeostasis, or inhibit hyperglucagonemia.


技術優勢

Improved glucose homeostasisSpecific enzyme pathway regulation


技術應用

Medical/HealthcarePharmaceuticals


詳細技術說明

Arun GhoshGhosh GroupPurdue Chemistry


國家

United States


申請號碼

None


國家/地區

美國

欲了解更多信息,請點擊 這裡
Business of IP Asia Forum
桌面版